Avidity Biosciences, Inc. (RNA)
71.75
-0.08
(-0.11%)
USD |
NASDAQ |
Dec 15, 14:46
Avidity Biosciences Research and Development Expense (Quarterly): 154.95M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Novartis AG | 2.857B |
| Dyne Therapeutics, Inc. | 97.22M |
| EXACT Sciences Corp. | 117.22M |
| Astria Therapeutics, Inc. | 24.15M |
| Intellia Therapeutics, Inc. | 92.33M |